Literature DB >> 19198938

Antimicrobial susceptibility testing of Helicobacter pylori determined by microdilution method using a new medium.

Francesca Sisto1, Maria Maddalena Scaltrito, Giuseppe Russello, Arianna Bonomi, Francesco Dubini.   

Abstract

Antibiotic susceptibility testing of Helicobacter pylori isolates was performed by broth microdilution method with MegaCell RPMI-1640 Medium (SIGMA). Fifty five clinical isolates of H. pylori were tested against metronidazole, tinidazole, amoxicillin, and clarithromycin. The results were compared to those obtained by standard agar dilution method. The microdilution method performed with new medium, showed excellent correlation with agar dilution results, with 100% agreement for metronidazole, 96.3% for amoxicillin, 90.7% for clarithromycin, and 92.8% for tinidazole. MICs determined by proposed method were highly reproducible: replicate results were variable within one-two-fold dilution by using different inocula and different batches of medium.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19198938     DOI: 10.1007/s00284-009-9368-0

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  17 in total

1.  Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.

Authors:  P Malfertheiner; F Megraud; C O'Morain; F Bazzoli; E El-Omar; D Graham; R Hunt; T Rokkas; N Vakil; E J Kuipers
Journal:  Gut       Date:  2006-12-14       Impact factor: 23.059

2.  Comparative evaluation of the E test, agar dilution, and broth microdilution for testing susceptibilities of Helicobacter pylori strains to 20 antimicrobial agents.

Authors:  R Piccolomini; G Di Bonaventura; G Catamo; F Carbone; M Neri
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

3.  Metronidazole and clarithromycin resistance in Helicobacter pylori determined by measuring MICs of antimicrobial agents in color indicator egg yolk agar in a miniwell format. The Gastrointestinal Physiology Working Group of Universidad Peruana Cayetano Heredia and the Johns Hopkins University.

Authors:  A Vasquez; Y Valdez; R H Gilman; J J McDonald; T U Westblom; D Berg; H Mayta; V Gutierrez
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

4.  Antimicrobial susceptibility of Helicobacter pylori determined by the E test using tetrazolium egg yolk agar.

Authors:  Y Valdez; B Velapatiño; R H Gilman; V Gutierrez; C León
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

5.  Correlation between substitutions in penicillin-binding protein 1 and amoxicillin resistance in Helicobacter pylori.

Authors:  Emiko Rimbara; Norihisa Noguchi; Takashi Kawai; Masanori Sasatsu
Journal:  Microbiol Immunol       Date:  2007       Impact factor: 1.955

6.  Changing pattern of antimicrobial resistance of Helicobacter pylori in Korean patients with peptic ulcer diseases.

Authors:  Chang Soo Eun; Dong Soo Han; Joon Yong Park; Yong Cheol Jeon; Joon Soo Hahm; Kyung Suk Kim; Jung Oak Kang
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

7.  Metronidazole susceptibility testing for Helicobacter pylori: comparison of disk, broth, and agar dilution methods and their clinical relevance.

Authors:  A J DeCross; B J Marshall; R W McCallum; S R Hoffman; L J Barrett; R L Guerrant
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

Review 8.  Helicobacter pylori detection and antimicrobial susceptibility testing.

Authors:  Francis Mégraud; Philippe Lehours
Journal:  Clin Microbiol Rev       Date:  2007-04       Impact factor: 26.132

9.  Prevalence and evolution of Helicobacter pylori resistance to 6 antibacterial agents over 12 years and correlation between susceptibility testing methods.

Authors:  Lyudmila Boyanova; Galina Gergova; Rossen Nikolov; Lubomir Davidkov; Victor Kamburov; Christo Jelev; Ivan Mitov
Journal:  Diagn Microbiol Infect Dis       Date:  2008-01-14       Impact factor: 2.803

10.  Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates.

Authors:  M Romano; M R Iovene; M I Russo; A Rocco; R Salerno; D Cozzolino; A P Pilloni; M A Tufano; D Vaira; G Nardone
Journal:  J Clin Pathol       Date:  2008-08-28       Impact factor: 3.411

View more
  4 in total

1.  E-Test or Agar Dilution for Metronidazole Susceptibility Testing of Helicobacter pylori: Importance of the Prevalence of Metronidazole Resistance.

Authors:  Jinnan Chen; Yu Huang; Zhaohui Ding; Xiao Liang; Hong Lu
Journal:  Front Microbiol       Date:  2022-03-14       Impact factor: 5.640

2.  In Vitro Activity of the Arylaminoartemisinin GC012 against Helicobacter pylori and Its Effects on Biofilm.

Authors:  Francesca Sisto; Simone Carradori; Sarah D'Alessandro; Nadia Santo; Norma Lattuada; Richard K Haynes; Donatella Taramelli; Rossella Grande
Journal:  Pathogens       Date:  2022-06-29

3.  Identifying potential novel drugs against Helicobacter pylori by targeting the essential response regulator HsrA.

Authors:  Andrés González; Sandra Salillas; Adrián Velázquez-Campoy; Vladimir Espinosa Angarica; María F Fillat; Javier Sancho; Ángel Lanas
Journal:  Sci Rep       Date:  2019-08-05       Impact factor: 4.379

4.  Synthesis and Evaluation of Thymol-Based Synthetic Derivatives as Dual-Action Inhibitors against Different Strains of H. pylori and AGS Cell Line.

Authors:  Francesca Sisto; Simone Carradori; Paolo Guglielmi; Mattia Spano; Daniela Secci; Arianna Granese; Anatoly P Sobolev; Rossella Grande; Cristina Campestre; Maria Carmela Di Marcantonio; Gabriella Mincione
Journal:  Molecules       Date:  2021-03-24       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.